Recent News

• 06 March 2025   News

  Enamine REAL Compounds: A Practical Overview

  Event Timing: Thursday, 24 April, 2025. Event Address: Suwon Convention Center, room 301+302.

• 26 February 2025   Press Release

  Enamine, Chemspace, and PharmAI Discovery Join Forces to Advance AI-Driven Drug Discovery for Novel Theranostics

  Enamine, Chemspace, and PharmAI Discovery GmbH (PAID) start a transformative collaboration to accelerate the advancement of theranostics through AI-driven drug discovery with emphasis on cancer diagnosis and therapy. This collaboration brings together the success of Enamine’s discovery biology and chemistry competencies, Chemspace’s expertise in ultra-large chemical space exploration for drug discovery, and PAID’s AI-powered molecular discovery platform to identify and develop promising drug candidates faster and with greater precision, both for conventional and molecular radiotherapy and radio diagnostics.

• 03 December 2024   Press Release

  Elsevier Adds 43 Million Enamine Make-on-Demand Compounds to Reaxys to Accelerate Chemistry R&D

  Elsevier, a global leader in information and analytics, and Enamine, a global leader in supplying small molecules and early drug discovery services, have announced a partnership to integrate Enamine's database of over 43 million make-on-demand (MADE) analog compounds into Reaxys. The integration will provide chemists with unparalleled access to a diverse array of chemical compounds for accelerated drug discovery and materials science research.